Weekly schedule of docetaxel in breast cancer: Evaluation of response and toxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Weekly schedule of docetaxel in breast cancer: Evaluation of response and toxicity

Published:2003-01 Issue:1 Volume:10 Page:10-14
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Kuroi Katsumasa,Bando Hiroko,Saji Shigehira,Toi Masakazu

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02967619.pdf

Reference28 articles.

1. Bonneterre J, Spielman M, Guastalla JP,et al: Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience.Eur J Cancer 35: 1431–1439, 1999.

2. Adachi I, Watanabe T, Takashima S,et al: A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.Br J Cancer 73: 210–216, 1996.

3. Fumoleau P, Chevallier B, Kerbrat P,et al: A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC.Ann Oncol 7: 165–171, 1996.

4. O’Brien ME, Leonard RC, Barrett-Lee PJ,et al: Docetaxel in the community setting: an analysis of 377 breast cancer patients treated with docetaxel (Taxotere) in the UK UK Study Group.Ann Oncol 10: 205–210, 1999.

5. Salminen E, Bergman M, Huhtala S,et al: Docetaxel: standard recommended dose of 100 mg/m2 is effective but not feasible for some metastatic breast cancer patients heavily pretreated with chemotherapy-A phase II single-center study.J Clin Oncol 17: 1127, 1999.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pharmacometrics model to define docetaxel target in early breast cancer;British Journal of Clinical Pharmacology;2022-09-28

2. The influence of docetaxel schedule on treatment tolerability and efficacy in patients with metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials;BMC Cancer;2022-01-25

3. Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours;Drugs in R&D;2021-01-19

4. Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis;Cancer Research and Treatment;2012-03-31

5. Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase II study;Breast Cancer;2011-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3